Document is current
Any future updates will be listed below
-
Authors
Dumas, Olivia
Rozza, Nicholas
Cheishvili, David
Luk, Sharon
Sin, Sarah T. K.
Khassenova, Alua
Kremer, Richard
Szyf, Moshe
Mihalcioiu, Catalin
Rabbani, Shafaat A.
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 28 July 2025
First Online: 21 August 2025
Declarations
:
: M.S. is the founder and shareholder of HKG Epitherapeutics Ltd. and EpiMedTech Global Ltd. EpiMedTech Global Ltd. has applied for patent protection for the epiMelanoma and pan-cancer tests and markers described in this paper. S.L., S.T.K.S., and A.K. are employees of HKG Epitherapeutics Ltd. D.C. serves as a consultant to HKG Epitherapeutics Ltd. All other authors declare no potential conflicts of interest.
: All samples were collected at McGill University Health Centre (MUHC) following the approval of the MUHC Research Ethics Board (MUHC-REB), and written consent was obtained from all participants.
